BiotechTube
Home/Nektar Therapeutics/Jonathan Zalevsky, Ph.D.
JZ

Jonathan Zalevsky, Ph.D.

Chief Research & Development Officer

Nektar Therapeutics

Therapeutic Areas

Autoimmune DiseasesInflammatory Diseases

Nektar Therapeutics Pipeline

DrugIndicationPhase
RezpegaldesleukinAtopic DermatitisPhase 2b
NKTR-0165Ulcerative Colitis, Vitiligo, Multiple SclerosisPreclinical

Leadership Team at Nektar Therapeutics

HW
Howard W. Robin
President & Chief Executive Officer
RB
Robert Bacci
Chief People Officer & Head of Quality & Facilities
JB
Jason Barnard
Chief Accounting Officer
View full Nektar Therapeutics profile